相关实验视频

Updated: Jul 11, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

杜皮卢马布增强了简单疹病毒1型特异性免疫反应在亚托皮肤炎

Stephan Traidl¹, Leonard Harries², Petra Kienlin²

¹Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.

The Journal of allergy and clinical immunology

|September 3, 2023

概括

在阿托皮性皮肤炎 (AD) 患者中,杜皮卢马布治疗有疹疹 (EH) 病史的患者可能会改善单纯疹病毒 (HSV-1) 免疫反应. 这种疗法减少HSV-1特异性IgE,增强1型免疫力,可能降低EH发病率.

科学领域:

免疫学免疫学免疫学
皮肤病学皮肤病学
病毒学病毒学

背景情况:

亚托匹性皮肤炎 (AD) 患者的病毒清除受损,容易受到严重的简单疹病毒 (HSV) 感染,称为疹疹 (EH).
在EH患者中已经确定了2型倾斜免疫反应.
临床观察表明dupilumab可能会降低AD中的EH发病率,但潜在的免疫机制需要研究.

研究的目的:

调查dupilumab对阿兹海默病患者的单纯疹病毒1型 (HSV-1) 特定免疫反应的影响.
为了比较ADH患者的免疫反应,有史以来的EH (ADEH+) 与没有 (ADEH-),有或没有dupilumab治疗.

主要方法:

测量了针对HSV-1糖蛋白D的血清IgE水平.
用HSV刺激了周围血液单核细胞 (PBMC).
流细胞计用于表征激活的CD4+和CD8+T细胞.
从HSV-1反应性T细胞系和特定的CD8+T细胞中分析了细胞因子的产生.

主要成果:

在ADEH+患者中,HSV-1特异性IgE水平升高,在dupilumab治疗时显著下降,达到健康的对照水平.
在ADEH患者中,dupilumab治疗与HSV-1特异性T_C1细胞频率升高有关.
在dupilumab治疗期间,没有观察到HSV-1特异性T_H细胞频率的显著变化.
与未服用杜皮卢马布的AD患者相比,在HSV-1特异性T细胞中增加了IFN-γ和减少了IL-4的产生.

结论:

杜皮卢马布可能会增强阿尔茨海默病患者的HSV-1特异性免疫反应.
这种改善似乎是由1型免疫反应的增加和HSV-1特异性IgE的减少促成的.
杜皮卢马布的这些免疫调节作用可能有助于观察到的EH发病率的减少.

关键词:

亚托邦性皮肤炎 (Atopic Dermatitis) 是一种疾病.双重复制的马布.湿疹疹 (herpeticum) 是一种疾病.简单性疹病毒1型

更多相关视频

Isolation of Lymphocytes from Mouse Genital Tract Mucosa

Isolation of Lymphocytes from Mouse Genital Tract Mucosa

Published on: September 3, 2012

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

Published on: October 28, 2019

相关概念视频

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

Herpes

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...

Genital Herpes

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...